ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Azole Antifungals Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-5U16978
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Azole Antifungals Market Research Report 2024
BUY CHAPTERS

Global Azole Antifungals Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-5U16978
Report
November 2025
Pages:170
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Novartis
Sanofi Aventis
Enzon Pharmaceuticals
Bayer
Astellas Pharma
Abbott
Viatris (MYLAN)
Cipla Ltd
Sun Pharma

Azole Antifungals Market

The global Azole Antifungals market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Azole antifungals are a class of drugs widely used to treat fungal infections and work primarily by inhibiting fungal growth and reproduction.
From a downstream perspective, Medical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Azole Antifungals leading manufacturers including Merck, Novartis, Pfizer, Sanofi-Aventis, Enzon Pharmaceuticals, Bayer, Astellas Pharma, GlaxoSmithKline, Abbott, Viatris (Mylan), etc., dominate supply; the top five capture approximately % of global revenue, with Merck leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Azole Antifungals market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Azole Antifungals Market Report

Report Metric Details
Report Name Azole Antifungals Market
Segment by Type
  • Imidazoles
  • Cinnamates
  • Others
Segment by Application
  • Medical
  • Agriculture
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Novartis, Pfizer, Sanofi-Aventis, Enzon Pharmaceuticals, Bayer, Astellas Pharma, GlaxoSmithKline, Abbott, Viatris (Mylan), Cipla, Sun Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Azole Antifungals study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Azole Antifungals Market report?

Ans: The main players in the Azole Antifungals Market are Merck, Novartis, Pfizer, Sanofi-Aventis, Enzon Pharmaceuticals, Bayer, Astellas Pharma, GlaxoSmithKline, Abbott, Viatris (Mylan), Cipla, Sun Pharma

What are the Application segmentation covered in the Azole Antifungals Market report?

Ans: The Applications covered in the Azole Antifungals Market report are Medical, Agriculture, Others

What are the Type segmentation covered in the Azole Antifungals Market report?

Ans: The Types covered in the Azole Antifungals Market report are Imidazoles, Cinnamates, Others

1 Study Coverage
1.1 Introduction to Azole Antifungals: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Azole Antifungals Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Imidazoles
1.2.3 Cinnamates
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Azole Antifungals Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Agriculture
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Azole Antifungals Revenue Estimates and Forecasts 2020-2031
2.2 Global Azole Antifungals Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Azole Antifungals Sales Estimates and Forecasts 2020-2031
2.4 Global Azole Antifungals Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Azole Antifungals Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Azole Antifungals Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Azole Antifungals Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Imidazoles Market Size by Manufacturers
4.5.2 Cinnamates Market Size by Manufacturers
4.5.3 Others Market Size by Manufacturers
4.6 Global Azole Antifungals Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Azole Antifungals Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Azole Antifungals Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Azole Antifungals Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Azole Antifungals Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Azole Antifungals Sales and Revenue by Type (2020-2031)
7.4 North America Azole Antifungals Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Azole Antifungals Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Azole Antifungals Sales and Revenue by Type (2020-2031)
8.4 Europe Azole Antifungals Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Azole Antifungals Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Azole Antifungals Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Azole Antifungals Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Azole Antifungals Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Azole Antifungals Sales and Revenue by Type (2020-2031)
10.4 Central and South America Azole Antifungals Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Azole Antifungals Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Azole Antifungals Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Azole Antifungals Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Azole Antifungals Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Azole Antifungals Product Models, Descriptions and Specifications
12.1.4 Merck Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Merck Azole Antifungals Sales by Product in 2024
12.1.6 Merck Azole Antifungals Sales by Application in 2024
12.1.7 Merck Azole Antifungals Sales by Geographic Area in 2024
12.1.8 Merck Azole Antifungals SWOT Analysis
12.1.9 Merck Recent Developments
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Azole Antifungals Product Models, Descriptions and Specifications
12.2.4 Novartis Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Novartis Azole Antifungals Sales by Product in 2024
12.2.6 Novartis Azole Antifungals Sales by Application in 2024
12.2.7 Novartis Azole Antifungals Sales by Geographic Area in 2024
12.2.8 Novartis Azole Antifungals SWOT Analysis
12.2.9 Novartis Recent Developments
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Azole Antifungals Product Models, Descriptions and Specifications
12.3.4 Pfizer Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Pfizer Azole Antifungals Sales by Product in 2024
12.3.6 Pfizer Azole Antifungals Sales by Application in 2024
12.3.7 Pfizer Azole Antifungals Sales by Geographic Area in 2024
12.3.8 Pfizer Azole Antifungals SWOT Analysis
12.3.9 Pfizer Recent Developments
12.4 Sanofi-Aventis
12.4.1 Sanofi-Aventis Corporation Information
12.4.2 Sanofi-Aventis Business Overview
12.4.3 Sanofi-Aventis Azole Antifungals Product Models, Descriptions and Specifications
12.4.4 Sanofi-Aventis Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Sanofi-Aventis Azole Antifungals Sales by Product in 2024
12.4.6 Sanofi-Aventis Azole Antifungals Sales by Application in 2024
12.4.7 Sanofi-Aventis Azole Antifungals Sales by Geographic Area in 2024
12.4.8 Sanofi-Aventis Azole Antifungals SWOT Analysis
12.4.9 Sanofi-Aventis Recent Developments
12.5 Enzon Pharmaceuticals
12.5.1 Enzon Pharmaceuticals Corporation Information
12.5.2 Enzon Pharmaceuticals Business Overview
12.5.3 Enzon Pharmaceuticals Azole Antifungals Product Models, Descriptions and Specifications
12.5.4 Enzon Pharmaceuticals Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Enzon Pharmaceuticals Azole Antifungals Sales by Product in 2024
12.5.6 Enzon Pharmaceuticals Azole Antifungals Sales by Application in 2024
12.5.7 Enzon Pharmaceuticals Azole Antifungals Sales by Geographic Area in 2024
12.5.8 Enzon Pharmaceuticals Azole Antifungals SWOT Analysis
12.5.9 Enzon Pharmaceuticals Recent Developments
12.6 Bayer
12.6.1 Bayer Corporation Information
12.6.2 Bayer Business Overview
12.6.3 Bayer Azole Antifungals Product Models, Descriptions and Specifications
12.6.4 Bayer Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Bayer Recent Developments
12.7 Astellas Pharma
12.7.1 Astellas Pharma Corporation Information
12.7.2 Astellas Pharma Business Overview
12.7.3 Astellas Pharma Azole Antifungals Product Models, Descriptions and Specifications
12.7.4 Astellas Pharma Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Astellas Pharma Recent Developments
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Corporation Information
12.8.2 GlaxoSmithKline Business Overview
12.8.3 GlaxoSmithKline Azole Antifungals Product Models, Descriptions and Specifications
12.8.4 GlaxoSmithKline Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 GlaxoSmithKline Recent Developments
12.9 Abbott
12.9.1 Abbott Corporation Information
12.9.2 Abbott Business Overview
12.9.3 Abbott Azole Antifungals Product Models, Descriptions and Specifications
12.9.4 Abbott Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Abbott Recent Developments
12.10 Viatris (Mylan)
12.10.1 Viatris (Mylan) Corporation Information
12.10.2 Viatris (Mylan) Business Overview
12.10.3 Viatris (Mylan) Azole Antifungals Product Models, Descriptions and Specifications
12.10.4 Viatris (Mylan) Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Viatris (Mylan) Recent Developments
12.11 Cipla
12.11.1 Cipla Corporation Information
12.11.2 Cipla Business Overview
12.11.3 Cipla Azole Antifungals Product Models, Descriptions and Specifications
12.11.4 Cipla Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Cipla Recent Developments
12.12 Sun Pharma
12.12.1 Sun Pharma Corporation Information
12.12.2 Sun Pharma Business Overview
12.12.3 Sun Pharma Azole Antifungals Product Models, Descriptions and Specifications
12.12.4 Sun Pharma Azole Antifungals Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Sun Pharma Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Azole Antifungals Industry Chain
13.2 Azole Antifungals Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Azole Antifungals Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Azole Antifungals Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Azole Antifungals Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Azole Antifungals Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Merck
Novartis
Sanofi Aventis
Enzon Pharmaceuticals
Bayer
Astellas Pharma
Abbott
Viatris (MYLAN)
Cipla Ltd
Sun Pharma
List of Tables
 Table 1. Global Azole Antifungals Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Azole Antifungals Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Azole Antifungals Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Azole Antifungals Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Azole Antifungals Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Azole Antifungals Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 7. Global Azole Antifungals Sales by Region (2020-2025) & (Kilotons)
 Table 8. Global Azole Antifungals Sales by Region (2026-2031) & (Kilotons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Azole Antifungals Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 11. Global Azole Antifungals Production by Region (2020-2025) & (Kilotons)
 Table 12. Global Azole Antifungals Production by Region (2026-2031) & (Kilotons)
 Table 13. Global Azole Antifungals Sales by Manufacturers (2020-2025) & (Kilotons)
 Table 14. Global Azole Antifungals Sales Share by Manufacturers (2020-2025)
 Table 15. Global Azole Antifungals Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Azole Antifungals Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Azole Antifungals by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Azole Antifungals as of 2024)
 Table 19. Global Azole Antifungals Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Azole Antifungals Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Azole Antifungals Manufacturing Base and Headquarters
 Table 22. Global Azole Antifungals Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Azole Antifungals Sales by Type (2020-2025) & (Kilotons)
 Table 26. Global Azole Antifungals Sales by Type (2026-2031) & (Kilotons)
 Table 27. Global Azole Antifungals Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Azole Antifungals Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Azole Antifungals ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Azole Antifungals Sales by Application (2020-2025) & (Kilotons)
 Table 32. Global Azole Antifungals Sales by Application (2026-2031) & (Kilotons)
 Table 33. Azole Antifungals High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Azole Antifungals Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Azole Antifungals Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Azole Antifungals ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Azole Antifungals Growth Accelerators and Market Barriers
 Table 40. North America Azole Antifungals Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Azole Antifungals Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Azole Antifungals Growth Accelerators and Market Barriers
 Table 43. Europe Azole Antifungals Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Azole Antifungals Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Azole Antifungals Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Azole Antifungals Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Azole Antifungals Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Azole Antifungals Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Azole Antifungals Investment Opportunities and Key Challenges
 Table 50. Central and South America Azole Antifungals Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Azole Antifungals Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Azole Antifungals Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Merck Corporation Information
 Table 54. Merck Description and Major Businesses
 Table 55. Merck Product Models, Descriptions and Specifications
 Table 56. Merck Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Merck Sales Value Proportion by Product in 2024
 Table 58. Merck Sales Value Proportion by Application in 2024
 Table 59. Merck Sales Value Proportion by Geographic Area in 2024
 Table 60. Merck Azole Antifungals SWOT Analysis
 Table 61. Merck Recent Developments
 Table 62. Novartis Corporation Information
 Table 63. Novartis Description and Major Businesses
 Table 64. Novartis Product Models, Descriptions and Specifications
 Table 65. Novartis Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Novartis Sales Value Proportion by Product in 2024
 Table 67. Novartis Sales Value Proportion by Application in 2024
 Table 68. Novartis Sales Value Proportion by Geographic Area in 2024
 Table 69. Novartis Azole Antifungals SWOT Analysis
 Table 70. Novartis Recent Developments
 Table 71. Pfizer Corporation Information
 Table 72. Pfizer Description and Major Businesses
 Table 73. Pfizer Product Models, Descriptions and Specifications
 Table 74. Pfizer Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Pfizer Sales Value Proportion by Product in 2024
 Table 76. Pfizer Sales Value Proportion by Application in 2024
 Table 77. Pfizer Sales Value Proportion by Geographic Area in 2024
 Table 78. Pfizer Azole Antifungals SWOT Analysis
 Table 79. Pfizer Recent Developments
 Table 80. Sanofi-Aventis Corporation Information
 Table 81. Sanofi-Aventis Description and Major Businesses
 Table 82. Sanofi-Aventis Product Models, Descriptions and Specifications
 Table 83. Sanofi-Aventis Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Sanofi-Aventis Sales Value Proportion by Product in 2024
 Table 85. Sanofi-Aventis Sales Value Proportion by Application in 2024
 Table 86. Sanofi-Aventis Sales Value Proportion by Geographic Area in 2024
 Table 87. Sanofi-Aventis Azole Antifungals SWOT Analysis
 Table 88. Sanofi-Aventis Recent Developments
 Table 89. Enzon Pharmaceuticals Corporation Information
 Table 90. Enzon Pharmaceuticals Description and Major Businesses
 Table 91. Enzon Pharmaceuticals Product Models, Descriptions and Specifications
 Table 92. Enzon Pharmaceuticals Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Enzon Pharmaceuticals Sales Value Proportion by Product in 2024
 Table 94. Enzon Pharmaceuticals Sales Value Proportion by Application in 2024
 Table 95. Enzon Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
 Table 96. Enzon Pharmaceuticals Azole Antifungals SWOT Analysis
 Table 97. Enzon Pharmaceuticals Recent Developments
 Table 98. Bayer Corporation Information
 Table 99. Bayer Description and Major Businesses
 Table 100. Bayer Product Models, Descriptions and Specifications
 Table 101. Bayer Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Bayer Recent Developments
 Table 103. Astellas Pharma Corporation Information
 Table 104. Astellas Pharma Description and Major Businesses
 Table 105. Astellas Pharma Product Models, Descriptions and Specifications
 Table 106. Astellas Pharma Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Astellas Pharma Recent Developments
 Table 108. GlaxoSmithKline Corporation Information
 Table 109. GlaxoSmithKline Description and Major Businesses
 Table 110. GlaxoSmithKline Product Models, Descriptions and Specifications
 Table 111. GlaxoSmithKline Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. GlaxoSmithKline Recent Developments
 Table 113. Abbott Corporation Information
 Table 114. Abbott Description and Major Businesses
 Table 115. Abbott Product Models, Descriptions and Specifications
 Table 116. Abbott Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. Abbott Recent Developments
 Table 118. Viatris (Mylan) Corporation Information
 Table 119. Viatris (Mylan) Description and Major Businesses
 Table 120. Viatris (Mylan) Product Models, Descriptions and Specifications
 Table 121. Viatris (Mylan) Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. Viatris (Mylan) Recent Developments
 Table 123. Cipla Corporation Information
 Table 124. Cipla Description and Major Businesses
 Table 125. Cipla Product Models, Descriptions and Specifications
 Table 126. Cipla Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 127. Cipla Recent Developments
 Table 128. Sun Pharma Corporation Information
 Table 129. Sun Pharma Description and Major Businesses
 Table 130. Sun Pharma Product Models, Descriptions and Specifications
 Table 131. Sun Pharma Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 132. Sun Pharma Recent Developments
 Table 133. Key Raw Materials Distribution
 Table 134. Raw Materials Key Suppliers
 Table 135. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 136. Milestones in Production Technology Evolution
 Table 137. Distributors List
 Table 138. Market Trends and Market Evolution
 Table 139. Market Drivers and Opportunities
 Table 140. Market Challenges, Risks, and Restraints
 Table 141. Research Programs/Design for This Report
 Table 142. Key Data Information from Secondary Sources
 Table 143. Key Data Information from Primary Sources


List of Figures
 Figure 1. Azole Antifungals Product Picture
 Figure 2. Global Azole Antifungals Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Imidazoles Product Picture
 Figure 4. Cinnamates Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Azole Antifungals Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Medical
 Figure 8. Agriculture
 Figure 9. Others
 Figure 10. Azole Antifungals Report Years Considered
 Figure 11. Global Azole Antifungals Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Azole Antifungals Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Azole Antifungals Revenue Market Share by Region (2020-2031)
 Figure 15. Global Azole Antifungals Sales (2020-2031) & (Kilotons)
 Figure 16. Global Azole Antifungals Sales (CAGR) by Region (2020-2031) (Kilotons)
 Figure 17. Global Azole Antifungals Sales Market Share by Region (2020-2031)
 Figure 18. Global Azole Antifungals Capacity, Production and Utilization (2020-2031) & (Kilotons)
 Figure 19. Global Azole Antifungals Production Trend by Region (2020-2031) (Kilotons)
 Figure 20. Global Azole Antifungals Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. Azole Antifungals Production Growth Rate in North America (2020-2031) & (Kilotons)
 Figure 23. Azole Antifungals Production Growth Rate in Europe (2020-2031) & (Kilotons)
 Figure 24. Azole Antifungals Production Growth Rate in China (2020-2031) & (Kilotons)
 Figure 25. Azole Antifungals Production Growth Rate in Japan (2020-2031) & (Kilotons)
 Figure 26. Top 5 and Top 10 Manufacturers Azole Antifungals Sales Volume Market Share in 2024
 Figure 27. Global Azole Antifungals Revenue Market Share Ranking (2024)
 Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 29. Imidazoles Revenue Market Share by Manufacturer in 2024
 Figure 30. Cinnamates Revenue Market Share by Manufacturer in 2024
 Figure 31. Others Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 34. Global Azole Antifungals Sales Market Share by Type (2020-2031)
 Figure 35. Global Azole Antifungals Revenue Market Share by Type (2020-2031)
 Figure 36. Global Azole Antifungals Sales Market Share by Application (2020-2031)
 Figure 37. Global Azole Antifungals Revenue Market Share by Application (2020-2031)
 Figure 38. North America Azole Antifungals Sales YoY (2020-2031) & (Kilotons)
 Figure 39. North America Azole Antifungals Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. North America Top 5 Manufacturers Azole Antifungals Sales Revenue (US$ Million) in 2024
 Figure 41. North America Azole Antifungals Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 42. North America Azole Antifungals Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 43. North America Azole Antifungals Sales Volume (Kilotons) by Application (2020-2031)
 Figure 44. North America Azole Antifungals Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. US Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 46. Canada Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 47. Mexico Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 48. Europe Azole Antifungals Sales YoY (2020-2031) & (Kilotons)
 Figure 49. Europe Azole Antifungals Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Europe Top 5 Manufacturers Azole Antifungals Sales Revenue (US$ Million) in 2024
 Figure 51. Europe Azole Antifungals Sales Volume (Kilotons) by Type (2020-2031)
 Figure 52. Europe Azole Antifungals Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 53. Europe Azole Antifungals Sales Volume (Kilotons) by Application (2020-2031)
 Figure 54. Europe Azole Antifungals Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Germany Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 56. France Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 57. U.K. Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 58. Italy Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 59. Russia Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific Azole Antifungals Sales YoY (2020-2031) & (Kilotons)
 Figure 61. Asia-Pacific Azole Antifungals Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Asia-Pacific Top 8 Manufacturers Azole Antifungals Sales Revenue (US$ Million) in 2024
 Figure 63. Asia-Pacific Azole Antifungals Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 64. Asia-Pacific Azole Antifungals Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 65. Asia-Pacific Azole Antifungals Sales Volume (Kilotons) by Application (2020-2031)
 Figure 66. Asia-Pacific Azole Antifungals Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Indonesia Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 68. Japan Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 69. South Korea Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 70. China Taiwan Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 71. India Azole Antifungals Revenue (2020-2031) & (US$ Million)
 Figure 72. Central and South America Azole Antifungals Sales YoY (2020-2031) & (Kilotons)
 Figure 73. Central and South America Azole Antifungals Revenue YoY (2020-2031) & (US$ Million)
 Figure 74. Central and South America Top 5 Manufacturers Azole Antifungals Sales Revenue (US$ Million) in 2024
 Figure 75. Central and South America Azole Antifungals Sales Volume (Kilotons) by Type (2021-2031)
 Figure 76. Central and South America Azole Antifungals Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 77. Central and South America Azole Antifungals Sales Volume (Kilotons) by Application (2020-2031)
 Figure 78. Central and South America Azole Antifungals Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 79. Brazil Azole Antifungals Revenue (2020-2025) & (US$ Million)
 Figure 80. Argentina Azole Antifungals Revenue (2020-2025) & (US$ Million)
 Figure 81. Middle East, and Africa Azole Antifungals Sales YoY (2020-2031) & (Kilotons)
 Figure 82. Middle East and Africa Azole Antifungals Revenue YoY (2020-2031) & (US$ Million)
 Figure 83. Middle East and Africa Top 5 Manufacturers Azole Antifungals Sales Revenue (US$ Million) in 2024
 Figure 84. Middle East and Africa Azole Antifungals Sales Volume (Kilotons) by Type (2021-2031)
 Figure 85. South America Azole Antifungals Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 86. Middle East and Africa Azole Antifungals Sales Volume (Kilotons) by Application (2020-2031)
 Figure 87. Middle East and Africa Azole Antifungals Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 88. GCC Countries Azole Antifungals Revenue (2020-2025) & (US$ Million)
 Figure 89. Turkey Azole Antifungals Revenue (2020-2025) & (US$ Million)
 Figure 90. Egypt Azole Antifungals Revenue (2020-2025) & (US$ Million)
 Figure 91. South Africa Azole Antifungals Revenue (2020-2025) & (US$ Million)
 Figure 92. Azole Antifungals Industry Chain Mapping
 Figure 93. Regional Azole Antifungals Manufacturing Base Distribution (%)
 Figure 94. Azole Antifungals Production Process
 Figure 95. Regional Azole Antifungals Production Cost Structure
 Figure 96. Channels of Distribution (Direct Vs Distribution)
 Figure 97. Bottom-up and Top-down Approaches for This Report
 Figure 98. Data Triangulation
 Figure 99. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Medical Antifungal Agent Market Research Report 2025
Global Anti fungal Drugs Market Insights Forecast to 2030
Antifungal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Azole Fungicide Market Research Report 2025
Global Fluconazole Preparation Market Research Report 2024
Global Posaconazole Market Research Report 2024
Global Antifungal Drugs for Skin Market Research Report 2024
Global Fenticonazole Market Research Report 2024
Global Anti Fungal Agents Market Insights Forecast to 2030
Fluconazole Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antimycotic Medication Market Insights Forecast to 2030
Itraconazole Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antifungal Susceptibility Testing Market Research Report 2024
Organic Industrial Antifungal Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fluconazole Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Topical Antifungals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Echinocandins Antifungal Drugs Market Research Report 2024
Global Anti Dermatomycosis Treatment Market Research Report 2025
Global Tebuconazole Market Research Report 2024
Global Enilconazole Market Insights Forecast to 2030

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions